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B/Ann Arbor/1/66
ts phenotypeor/1/66 is the master donor virus for inﬂuenza B (MDV-B) vaccine component of
live attenuated inﬂuenza FluMist® vaccine. The six internal protein gene segments of MDV-B confer the
characteristic cold-adapted (ca), temperature-sensitive (ts) and attenuated (att) phenotypes to the
reassortant vaccine strains that contain the HA and NA RNA segments from the circulating wild type
strains. Previously, we have mapped the loci in the NP, PA and M genes that determine the ca, ts and att
phenotypes of MDV-B. In this report, the ts mechanism of MDV-B was described by comparing replication of
MDV-B with its wild type counterpart at permissive and restricted temperatures. We showed that the PA and
NP proteins of MDV-B are defective in RNA polymerase function at the restricted temperature of 37 °C
resulting in greatly reduced viral RNA and protein synthesis. In addition, the twoM1 residues, Q159 and V183
that are unique to MDV-B, contribute to reduced virus replication at temperatures greater than 33 °C,
possibly due to the reduced M1 membrane association and its reduced virion M1 incorporation. Thus, the
previously identiﬁed MDV-B loci not only reduce viral polymerase function at the restricted temperature but
also affect virus assembly and release.
© 2008 Elsevier Inc. All rights reserved.Introduction
Inﬂuenza viruses are classiﬁed in the family of Orthomyxoviridae
that contains inﬂuenza type A, B, C and Thogovirus genera (Wright and
Webster, 2001). The enveloped viruses contain segmented, negative-
sense, single-stranded RNA genomes. Both inﬂuenza A and B viruses
co-circulate in humans and cause annual inﬂuenza epidemics that
result in signiﬁcant mobility and mortality worldwide (Simonsen et
al., 2000; Thompson et al., 2003). Inﬂuenza A viruses infect a wide
variety of species and have 16 hemagglutinin (HA) and 9 neuramini-
dase (NA) subtypes (Fouchier et al., 2005). The viruses constantly
undergo genetic changes to alter the antigenic sites and result in
antigenic drift. Reassortment of virus genomic segments between
different inﬂuenza A subtypes creates reassortant viruses (antigenic
shift) that can potentially cause inﬂuenza pandemics. Inﬂuenza B
viruses have only been isolated in humans and seals. Two anti-
genically distinct B virus lineages have been circulating in human
populations (Rota et al., 1990). New inﬂuenza B strains emerge mainly
by antigenic drift and occasionally by reassortment among different
inﬂuenza B viruses (McCullers et al., 1999).
Vaccination is the most effective means to prevent inﬂuenza
epidemics. Current inﬂuenza vaccines contain two type A strains
(H1N1 and H3N2) and one type B strain that are antigenically repre-l rights reserved.sentative of the strains that are predicted to circulate in the
forthcoming inﬂuenza season. FluMist®, a cold-adapted live attenu-
ated inﬂuenza vaccine delivered in spray to the nasal mucosa, has
been licensed for use in the U.S. since 2003. This vaccine has been
shown to be safe, well-tolerated and highly effective in preventing
inﬂuenza illness in both adults and children (Belshe et al., 2004;
Belshe and Gruber, 2001; Murphy and Coelingh, 2002). Large scale
clinical studies have demonstrated that live attenuated inﬂuenza
vaccine signiﬁcantly reduced the number of inﬂuenza cases compared
to inactivated vaccine in young children (Ashkenazi et al., 2006;
Belshe et al., 2007; Fleming et al., 2006). Each of the three 6:2
reassortant vaccines in FluMist® contains the HA and NA gene
segments from a currently circulating wild type (wt) strain (H1N1,
H3N2 or B) and the six internal protein gene segments (PB2, PB1, PA,
NP, M and NS) from the master donor virus (MDV) derived from either
cold-adapted A/Ann Arbor/6/60 (MDV-A) or B/Ann Arbor/1/66 strain
(MDV-B). The six internal gene segments of MDV impart the cold-
adapted (ca), temperature-sensitive (ts) and attenuation (att) pheno-
type to the vaccine strains.
MDV-B was produced by serial passage of the parental wt B/Ann
Arbor/1/66 at successively lower temperatures in primary chicken
kidney (PCK) cells. The resulting ca B/Ann Arbor/1/66 grows efﬁciently
at 25 °C (ca), but its growth is restricted at 37 °C (ts). It replicates in the
upper respiratory tract but not in the lower respiratory tract of the
infected ferrets (att) (Maassab and Bryant, 1999; Maassab and
DeBorde, 1985). MDV-B contains nine amino acids in the PB2, PA, NP
Fig. 1. Viral protein synthesis at different temperatures. MDCK cells were infected with
MDV-B or wt-B at an MOI of 4.0 and incubated at different temperatures (33, 37 and
38 °C). At 15 h postinfection, cells were labeled with 35S-Met/Cys for 30min. The labeled
cell lysates were analyzed on 12% denaturing polyacrylamide gel followed by
autoradiography.
355Z. Chen et al. / Virology 380 (2008) 354–362andM1 proteins that control the ca, ts, and att phenotypes (Chen et al.,
2006; Hoffmann et al., 2005). The ts loci of MDV-B have been mapped
to the three residues, one in PA (M431) and two in NP (A114 andH410).Fig. 2. Viral RNA synthesis at different temperatures. (A) MDCK cells were infected with MDV
for Northern blotting analysis using strand-speciﬁc NP or PB2 riboprobe to detect positive-s
using MDV-B-infected cells incubated at 33 °C for 15 h. Different amount of total RNA (lanes
using M segment speciﬁc primers to detect vRNA, mRNA and cRNA. (C) MDCK cells infected w
extension assay to distinguish mRNA from cRNA using NP, M or PA speciﬁc primers and toThese three ts loci and two amino acids in M1 (Q159 and V183) are
required for the expression of the att phenotype. The MDV-B ca loci
have been mapped to ﬁve residues located in PB2 (R630), PA (M431)
and NP (A114, H410 and T509).
In this report, we attempted to understand the molecular
mechanisms responsible for the ts phenotype by comparing replica-
tion of MDV-B with its wild type (wt) counterpart at permissive and
nonpermissive temperatures. We found that shut-off of viral RNA and
protein synthesis at nonpermissive temperature was caused by
defective functions of PA and NP. We further identiﬁed that the M1
protein of MDV-B contributed to inefﬁcient virus release and affected
multi-cycle replication at 33 °C and higher temperatures. Thus, the ts
phenotype is multigenically controlled and multiple gene products
contribute to the temperature-dependent replication of MDV-B.
Results
MDV-B protein synthesis was blocked at the nonpermissive temperatures
The master donor virus for inﬂuenza B vaccine strains, MDV-B, has
a characteristic ts phenotype; replication at 37 °C is restricted bymore
than 100-fold compared to 33 °C. Recombinant wild type B/Ann
Arbor/1/66 (wt-B) was produced by introducing wt-speciﬁc codons
into PB2, PA, NP and M1 segments of MDV-B to restore its genetic
sequence to that of wt-B; this virus was shown to have the non-ts and
non-att phenotypes that are identical to the biologically derived wt B/
Ann Arbor/1/66 (Hoffmann et al., 2005). To determine whether viral-B or Wt-B at an MOI of 4.0 at 33 or 38 °C for 6 h or 15 h. Total cellular RNAwas puriﬁed
ense or negative-sense viral RNAs as indicated. (B) Quantitative primer extension assay
1 to 7: 0.1, 0.5, 1.0, 2.0, 3.0, 4.0 and 5.0 μg) was used as templates for primer extension
ith MDV-B or Wt-B at an MOI of 4.0 at 33, 37 or 38 °C for 15 h were analyzed by primer
detect vRNA.
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reduced, MDCK cells were infected with MDV-B and wt-B at an MOI of
4.0, pulse-labeled with [35S]-methionine/cysteine, and cell lysates
were analyzed by gel electrophoresis. As shown in Fig. 1, viral protein
synthesis in MDV-B-infected cells was greatly reduced at 37 °C and
completely shut off at 38 °C. In contrast, wt-B had similar levels of
protein synthesized at 33, 37 and 38 °C (Fig. 1). Thus, viral protein
synthesis of MDV-B was reduced or shut off with the increased
temperatures.
Viral RNA synthesis was blocked in MDV-B-infected cells at the
nonpermissive temperatures
To evaluate viral RNA synthesis, expression of MDV-B vRNA, mRNA
and cRNA at a high MOI at the nonpermissive temperature was
measured. MDCK cells were infected with MDV-B or wt-B for 6 h or
15 h at both permissive and restricted temperatures and the RNAs
were examined by Northern blotting to detect positive-strand viral
RNA (mRNA and cRNA) and negative-strand viral RNA using sense-
speciﬁc riboprobes (Fig. 2A). Using NP- and PB2-gene-speciﬁc ribop-
robes, both positive- and negative-sense RNA species were reduced in
MDV-B-infected cells at 38 °C. In contrast, levels of these viral RNAs in
wt-B-infected cells at 38 °C were similar to 33 °C at 6 h postinfection
or only slightly lower than those 33 °C at 15 h postinfection. Similar
results were obtained using other viral gene-speciﬁc probes (data not
shown).
To quantify different viral RNA species in infected cells, levels of
mRNA, vRNA and cRNA were examined by a quantitative primer
extension assay. Total RNAs were isolated from virus-infected cells
that were incubated at different temperatures and subjected to the
primer extension assay with a pair of 32P-labeled primers speciﬁc to
positive-sense mRNA and cRNA or negative-sense viral vRNA. The
mRNA can be differentiated from cRNA because of 10–15 nt cappedFig. 3. Analysis of viral polymerase function by a minigenome system. (A) 293T cells were tra
MDV-B PA and/or NP replaced by that of wt alongwith the reporter plasmid expressing vRNA
ﬂuorescence microscopy and by ﬂow cytometry to quantitate the percentage of EGFP posit
representative of different experiments. (B) Detection of the level of EGFP protein by westeprimer extension from its 5′ end. With increasing amount of total
virus RNA, the three RNA species were quantitatively detected (Fig.
2B). Primer extension using primers speciﬁc to the three different viral
gene segments (NP, M and PA) showed that the levels of vRNA, mRNA
and cRNA in MDV-B-infected cells were reduced at 37 °C and barely
detectable at 38 °C, but the levels of wt-B RNAs were similar at these
three temperatures (Fig. 2C). It was noted that the ratio of the mRNA
and cRNA was different among these three different gene segments
because of their differential expression in infected cells. For NP and M,
levels of mRNAwere greater than cRNA. In contrast, the mRNA level of
the PA polymerase protein was much less than its cRNA.
Viral polymerase function was impaired at the nonpermissive
temperatures
Our previous results showed that speciﬁc amino acids in PA and NP
control the ts phenotype of MDV-B (Hoffmann et al., 2005). To conﬁrm
that the NP and PA gene segments are responsible for the impaired
viral polymerase function at the restricted temperatures, an inﬂuenza
EGFP minigenome system was used to test the function of these two
proteins (Hoffmann et al., 2000). The EGFP gene is ﬂanked by the viral
terminal noncoding sequences and under the control of the human
pol I promoter. The expression of the EGFP gene is dependent on the
viral polymerase function to synthesize positive-strand mRNA from
the negative-sense RNA transcript that is synthesized by the host pol I
polymerase. The 293T cells were transfected with four plasmids
encoding the PB1, PB2, PA and NP gene under the control of the host
pol II promoter, respectively, along with the EGFP reporter plasmid
(Fig 3A). At 48 h posttransfection, EGFP expression levels were
detected by ﬂuorescence microscopy and quantitative ﬂow cytometry.
As shown in Fig 3A, EGFP was expressed in the 293T cells transfected
with MDV-B polymerase plasmids at 33 °C (77%) but was greatly
reduced at 37 °C (6%). Substitution of the ts loci in the PA and NP genesnsfected with the indicated plasmids expressing MDV-B PB1, PB2, PA and NP or have the
-like EGFP gene at 37 or 33 °C. At 48 h posttransfection, EGFP expressionwas analyzed by
ive cells. The numbers indicated in each panel is obtained from the same image and is
rn blotting using anti-EGFP antibody.
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expression at 37 °C. Substitution of wt PA gene alone partially
restored the polymerase function at 37 °C, 22% cells expressed EGFP
whenwt PAwas transfected. The contribution of thewt NP gene to the
polymerase activity was not detected in the cells transfected with wt
NP alone, 5% cells expressed EGFP compared with 6% cells expressing
EGFP in the cells transfected with MDV-B plasmids. Thus, restoration
of the MDV-B polymerase required both wt PA and NP proteins,
indicating the contribution of the NP to the polymerase activity. These
data conﬁrmed our previous conclusion that PA played a greater role
in controlling the ts phenotype (Hoffmann et al., 2005). Western
blotting analysis of the EGFP protein produced in each of the
transfected cells conﬁrmed different levels of EGFP expressed in the
transfected cells (Fig. 3B). Thus, the minigenome assay indicated that
polymerase function contributed by MDV-B PA and NP proteins were
impaired at 37 °C resulting in defective viral RNA transcription and
replication.Fig. 4. The effect of the M1 gene on virus multi-cycle replication. CEK cells were infected wit
33 °C. (A) At 13 h postinfection the infected cells were labeled with 35S-Met/Cys for 30min. Th
48 h postinfection the infected cell monolayers were immunostained with an anti-inﬂuenza
blotting using an inﬂuenza B virus speciﬁc polyclonal antibody which detected the HA andThe M1 gene of MDV-B affects virus multi-cycle replication
We have previously shown that the two unique amino acids
(Q159 and V183) in the M1 gene of MDV-B contributed to the
attenuation (att) phenotype of MDV-B. The M1 gene was not
considered critical for controlling the ts phenotype as assessed by
differential virus replication at 33 and 37 °C (Hoffmann et al., 2005).
Subsequent determination of virus growth in CEK (chicken embryo
kidney) cells at a low MOI at different temperatures showed that
the MDV-B recombinant with wt PA and NP substitutions (wt PA/
NP) at 37 °C had N100-fold reduction in virus titer than the virus
that contained an additional wt M gene (wt PA/NP/M), indicating
that PA, NP and M1 genes are all implicated in the impaired
replication of MDV-B at 37 °C. Substitution of the two M1 amino
acids by those of wt in MDV-B and the 6:2 vaccine strains also
increased virus titer by 10 to 100-fold at 33 °C but not at 25 °C
(Chen et al., 2006). To investigate the mechanisms by which MDV-Bh 6:2 B/HK/330/01 (MDV-B M) or 5:3 B/HK/330/01 (wt M) segment at indicated MOIs at
e labeled cell lysates were analyzed on 12% denaturing polyacrylamide gel. (B) At 15 h or
virus polyclonal antibody. (C) Virus-infected cells were lysed and analyzed by western
NP proteins.
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replication of 6:2 B/HK/330/01 vaccine strain that contains MDV-B
M or the 5:3 reassortant B/HK/330/01 containing wt M, whose titers
differ by approximately 100-fold, was investigated for their protein
synthesis in the infected CEK cells. CEK cells were infected with
these two viruses at different MOIs (4, 0.4 and 0.04) for 13 h and
pulse-labeled with [35S]-methionine/cysteine for 30 min. The cell
lysates were analyzed by denaturing polyacrylamide gel electro-
phoresis (Fig. 4A). Both viruses had similar levels of proteins
synthesized at 13 h of postinfection, indicating that MDV-B M1
didn't affect virus entry and viral protein synthesis. Next, replication
of the viruses with M1 gene from either MDV-B or wt was further
examined by immunostaining of the infected CEK cells with
inﬂuenza B virus speciﬁc antibody (Fig. 4B). CEK cells infected with
viruses containing either MDV-B M or wt M at an MOI of 4 for 15 h
had approximately 100% cells infected, conﬁrming that virus entry
and replication were comparable between these two viruses. At MOI
of 0.004, a similar percentage of cells was infected at 15 h
postinfection for both viruses. At 48 h postinfection at an MOI of
0.004 to examine multi-cycle replication, the majority of the cells
were infected by the virus that contained wt M1; however, only a
very low percentage of cells was infected with the virus that
contained MDV-B M1. These data indicated that MDV-B M1 impaired
multi-cycle replication (Fig. 4B). Western blot analysis of the infected
cell extracts conﬁrmed that viral proteins accumulated in the
infected cells correlated to the immunostaining result (Fig. 4C). The
MDV-B M resulted in very little viral proteins detected in the
infected cells when the MOI of 0.004 was used. These data conﬁrmed
that MDV-B M1 caused inefﬁcient multi-cycle replication in the CEK
cells even at 33 °C.Fig. 5. Effect of the M1 gene on virus release. (A) CEK cells were infected with wt PA/NP (MD
supernatants and cell lysates were harvested at the indicated time points and analyzed by W
labeled with 35S-Met/Cys at 2–15 h postinfection. The virions released in the culture superna
proteins were examined on a 12% denaturing polyacrylamide gel.The two MDV-B speciﬁc M1 residues affect virus particle release
The above results indicated that the reduced multi-cycle replica-
tion of MDV-B caused by the MDV-B M1 gene may be due to the
defect in the later stages of virus replication cycle, such as virus
assembly and release. Thus, virus particles released into the culture
supernatants of the infected cells were examined by Western blotting
analysis. In this study, MDV-B recombinants containing wt PA/NP
(MDV-B M) was compared with the virus containing wt PA/NP/M (wt
M). CEK cells were infected with the two viruses at an MOI of 4 at
37 °C, the infected cell lysates and culture supernatants were
collected at different time points and subjected to Western blot
analysis. Similar to what have been presented earlier, the viruses
containing the M gene from either MDV-B or wt produced compar-
able amount of viral proteins in the infected cells from 6 to 16 h
postinfection (Fig. 5A, lower panel). However, the amount of viral
proteins released into the supernatants of cells infected with the virus
that contained MDV-B M was much lower than the virus with the wt
M (Fig. 5A, upper panel). These data indicated that although viral
protein synthesis was comparable, the M gene of MDV-B appeared to
result in reduced virion release.
Virions released from the infected cells were then examined by
radiolabeling (Fig. 5B). CEK cells were infected with wt PA/NP (MDV-B
M) or wt PA/NP/M (wt M) at an MOI of 4 and metabolically labeled
with [35S]-methionine/cysteine for 12 h. The radiolabeled virus
particles released from the infected cells were partially puriﬁed
through sucrose cushion and analyzed by polyacrylamide gel electro-
phoresis and the relative levels of viral proteins were measured by
densitometry (Fig. 5B). As expected, the amount of viral proteins
released from the cells infected with MDV-B M was lower than theV-B M) and wt PA/NP/M (wt M) at an MOI of 4 and incubated at 37 °C. The infected cell
estern blotting using a polyclonal antibody against MDV-B. (B) The infected cells were
tant were centrifuged through 25% sucrose cushion at 25,000 rpm for 1 h and the viral
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into MDV-B M1 containing virus was extremely low, at a level of
approximately 9% of the total detectable viral proteins, which was
signiﬁcantly lower than the virus that contained wt M (26%). A similar
result was obtained with the reassortant B/HK/330/01 with either
MDV-B M or wt M segment (data not shown). These data indicated
that incorporation of the MDV-B M1 into virions was signiﬁcantly
reduced and the reduced M1 protein in virions was likely due to
inefﬁcient virus assembly and release from the infected cells resulting
in defective virions that were unable to undergo efﬁcient multi-cycle
replication.
MDV-B M1 protein had reduced membrane association
The M1 matrix protein is the major driving force in virus
budding process through its association with cell membrane and
viral RNP to facilitate virus assembly and release from the infected
cells (Gomez-Puertas et al., 2000). The M1 membrane association is
thought to be facilitated by viral HA and NA integral membrane
proteins (Ali et al., 2000). To determine whether the M1 protein of
MDV-B has reduced membrane association, CEK cells were infected
with wt PA/NP (MDV-B M) or with wt PA/NP/M (wt M) at an MOI of
4 and radiolabeled with [35S]-Methionine/Cysteine at 13 h post-
infection for 30 min followed by 90 min chase. After pulse labeling
and chasing, the infected cells were lysed with hypotonic buffer and
the postnuclear fractions were subject to sucrose gradient to
separate the membrane (insoluble) and non-membrane (soluble)
fractions. After immunoprecipitation with viral speciﬁc antibodies,
the precipitated proteins were analyzed by polyacrylamide gel
electrophoresis. As shown in Fig. 6, the HA integral membrane
protein was mostly found in the insoluble membrane fractions (I).
The NP protein was mostly present in the soluble non-membrane
fractions (S). In the cells infected with the virus containing wt M,
most of the M1 protein (77% as determined by densitometry) was in
the membrane fraction. However, the virus that contained the
MDV-B M1 gene had more M1 protein in the soluble fraction than
in the membrane fraction (36% insoluble vs 64% soluble). Floatation
assay using reassortant B/HK/330/01 viruses with MDV-B M or wt M
segment also produced similar result (data not shown). These data
suggested that the M1 protein of MDV-B had reduced membraneFig. 6. TheM1membrane association. The CEK cells were infectedwith wt PA/NP (MDV-
B M) and wt PA/NP/M (wt M) at an MOI of 4 and labeled with 35S-Met/Cys at 13 h
postinfection. After 30 min of pulse followed by 90 min of chasing, the cells were
disrupted with hypotonic buffer and the postnuclear materials were subjected to
sucrose gradient centrifugation. The top 2 fractions were collected and combined as
membrane associated or insoluble fraction (I) and the bottom 3 fractions were
combined as non-membrane associated or soluble (S) fraction. Viral proteins in these
fractions were immunoprecipitated with a polyclonal antibody against MDV-B and
electrophoresed on a 12% denaturing polyacrylamide gel to detect HA, NP and M1
proteins. The relative amount of M1 protein in the insoluble and soluble fractions was
quantiﬁed by densitometry.association, which may be responsible for inefﬁcient virus assembly
and release.
Discussion
The master donor viruses used in producing reassortant FluMist®
vaccines for type A and type B inﬂuenza viruses (MDV-A and MDV-B)
confer the ca, ts and att phenotypes to the live attenuated inﬂuenza
vaccine strains. Unlike MDV-A that has the ts loci in the PB2, PB1 and
NP genes but has normal viral protein synthesis at the restrictive
temperatures (Chan et al., 2008; Odagiri et al., 1987), MDV-B viral
protein synthesis was greatly reduced at 37 °C and completely shut off
at 38 °C. Analysis of RNA synthesized in MDV-B-infected cells
demonstrated that viral transcription (mRNA synthesis) and genome
replication (cRNA and vRNA synthesis) were signiﬁcantly reduced at
the nonpermissive temperature due to defective polymerase function
of PA and NP. Thus, the ts phenotype exhibited by MDV-B was caused
by a mechanism different from MDV-A.
The ts loci of both MDV-A and MDV-B reside in the genes
composing the viral ribonucleoprotein (vRNP) complex including
PB1, PB2 and PA polymerase proteins and the NP (Lamb and Krug,
2001; Neumann et al., 2004). Using a minigenome system to analyze
viral polymerase function, we conﬁrmed that the speciﬁc changes in
both the PA and NP gene segments are responsible for the defective
replication of MDV-B at the restricted temperatures. Studies of
inﬂuenza A viruses indicated that PA is involved in endonuclease
cleavage of the capped RNA primers and elongation during RNA
synthesis as well as cap-binding and vRNA and cRNA promoter
binding (Fodor et al., 2002, 2003; Hara et al., 2006). PA was also
implicated in assembly of the virus particle (Regan et al., 2006). A ts
mutant with lesion in the PA has been reported to alter regulation of
viral protein synthesis by over production of the M1 protein (Herget
and Scholtissek, 1993). Another PA ts53 mutant reduced vRNA
synthesis due to defective assembly of a functional viral RNA
polymerase complex (Kawaguchi et al., 2005). NP has multiple
functions in viral RNA transcription, replication and intracellular
trafﬁcking by interacting with a wide variety of viral and cellular
factors, including the RNA, PB1, PB2, M1 and cellular polypeptides
(Portela and Digard, 2002). NP tsmutants affected migration of the NP
and M1 from cell nucleus to the cytoplasm, or vRNA synthesis
inhibition possibly by disrupting the NP RNA binding activity
(Mandler et al., 1991; Medcalf et al., 1999). None of the NP, PA ts
sites in MDV-B overlaps with the known ts loci in the reported
inﬂuenza A ts viruses. Our studies demonstrated the importance of
both PA and NP for virus transcription and replication. However, how
the PA and NP proteins affect virus replication at the restricted
temperatures remain to be identiﬁed. Previous studies on the
temperature-dependent replication of inﬂuenza A viruses showed
that nuclear export of the NP protein was inhibited and vRNA
accumulation was decreased at high temperature (41 °C) because of
the low thermal stability of the polymerase–cRNA complexes (Dalton
et al., 2006; Sakaguchi et al., 2003). Furthermore, Hsp70 has been
implicated in thermal inhibition of nuclear export of the vRNP
complex (Hirayama et al., 2004). However, the shut-off temperature
of MDV-B (37 °C) is much lower than MDV-A (39 °C), the nuclear
export defect found for the inﬂuenza A viruses is not applicable to
MDV-B.
In this study we also discovered the unique mechanism by which
M1 affected virus replication in a temperature-dependent manner. In
our previous studies, we showed that viruses containing the two
MDV-B speciﬁc M1 residues (Q159 and V183) replicated less
efﬁciently than those containing wt M1 residues (H159, M183) at
33 °C and higher temperatures, indicating that the MDV-B M1 speciﬁc
amino acids contribute to the attenuation (att) phenotype (Chen et al.,
2006). By comparing the amount of viral proteins synthesized in the
infected cells and released into the culture supernatant for the two
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showed that MDV-B M1 did not affect virus protein synthesis but
it signiﬁcantly reduced the number of virus particles released into
the culture supernatant. The inefﬁcient virus assembly and virion
release at the high temperatures caused by MDV-B M1 are likely
responsible for inefﬁcient multi-cycle replication of the viruses con-
taining MDV-B M1.
MDV-B M1 reduced virus replication at 33 °C or higher tempera-
tures. The level of reduction varies between different viruses, cell
substrates and temperatures. 6:2 vaccine strains had lower (10–to
100-fold) titer than the virus with wt M1 amino acids at the
permissive temperature of 33 °C. The 100-fold lower growth of 6:2
B/HK/330/01 made it difﬁcult to select the 6:2 B/HK/330/01
reassortant virus in CEK cells. Nevertheless, 6:2 B/HK/330/01 vaccine
was able to grow efﬁciently in chicken embryonated eggs for vaccine
production, although 5:3 B/HK/330/01 containing wt M segment is
dominant over 6:2 B/HK/330/01 in virus growth in eggs when both
viruses were infected. MDCK cells normally allow more efﬁcient
virus growth for B vaccine strains. The replication difference between
MDV-B M and wt M containing virus in MDCK cells was less apparent
than in CEK cells. However, the virus that has the PA and NP replaced
by those of wt replicated poorer than the virus with an additional M
gene replaced bywt at 37 °C (N2.0 log10), this difference is less obvious
at 33 °C (b1.0 log10) (Chen et al., 2006). The temperature-dependent
effect of MDV-B M1 indicates that M1 played an important role in the
attenuation of vaccine strains in the lower respiratory tract that has
temperature higher than the upper respiratory tract.
The M1 matrix protein is a major structural component of
inﬂuenza virus that lies underneath viral envelope (Lamb and Krug,
2001). Inﬂuenza A virus M1 protein is critical for viral morphogen-
esis and replication in infected cells (Baez et al., 1980; Bourmakina
and Garcia-Sastre, 2003; Liu et al., 2002; Yasuda et al., 1993) by
promoting nucleus-cytoplasmic export of viral RNPs and preventing
vRNP from reentering into nucleus through its interaction with vRNP
and NEP (Cros and Palese, 2003). The M1 also plays a critical role in
virus assembly and budding presumably by interacting with RNPs
and cytoplasmic tails of viral glycoproteins HA and NA on the plasma
membrane (Barman et al., 2001; Chen et al., 2007; Gomez-Puertas
et al., 2000; Nayak et al., 2004). The interaction of M1 with
membrane integral proteins HA and NA has been implicated by the
membrane ﬂoatation analysis (Ali et al., 2000; Carrasco et al., 2004;
Enami and Enami, 1996). Using a similar membrane ﬂotation
analysis, we demonstrated that MDV-B M1 has a relatively weaker
membrane association than the virus containing wt M1, which may
have caused inefﬁcient virus assembly and release. The N-terminal
portion (1–164aa) of M1 contains RNP binding and membrane
interaction domains (Gregoriade and Frangione, 1981; Noton et al.,
2007; Ye et al., 1999). The M1 C-terminal portion (165–252aa) has
been implicated in binding with RNA/RNP and efﬁcient incorpora-
tion of M1 into virus particles (Noton et al., 2007; Sha and Luo,
1997) and interact with the heat shock cognate protein 70 (Hsc70)
(Watanabe et al., 2006). A single amino acid change (N221S) in the
C-terminus of inﬂuenza B M1 from mouse adaptation is reported to
be associated with virus virulence (McCullers et al., 2005). The
MDV-B M1 Q159 and V183 residues are likely involved in membrane
association and/or interaction with other viral proteins that are
important for virus assembly and budding. Further structural studies
of inﬂuenza B M1 protein should help to understand how these two
MDV-B speciﬁc M1 residues affect M1 functions in a temperature-
dependent manner.
In summary, the unique amino acids in PA, NP and M1 determined
the genetic characteristics of MDV-B by affecting not only the
polymerase activity but also virus assembly and release. The complex-
ity of the mechanisms controlling the ca, ts and att phenotypes of
MDV-B ensures the stability of MDV-B used in the FluMist® seasonal
vaccine strains.Materials and methods
Viruses and cells
Recombinant inﬂuenza B viruses used in this study, including
MDV-B, wt recombinant (wt-B), recombinants with wt residue
substitutions in the PA, NP and M segments, and B/HK/330/01
recombinants, were produced by plasmid rescue as described
previously (Chen et al., 2006). Madin–Darby canine kidney (MDCK)
cells were originally obtained from European Collection of Cell
Cultures (ECACC) andmaintained inMEM containing 10% FBS. Chicken
embryo kidney (CEK) cells were obtained from Charles River
Laboratories (North Franklin, CT) and maintained in M199 medium
(Hyclone, Logan, UT).
Radiolabeling of virus-infected cells
To examine viral protein synthesis at the permissive and
nonpermissive temperatures, MDCK cells in 6-well plates were
mock infected or infected with each virus at an MOI (multiplicity of
infection) of 4 and incubated at different temperatures. At 15 h
postinfection (p.i.), cells were washed with methionine and cysteine-
free Dulbecco's modiﬁed Eagle's medium (Met−/Cys− DMEM; Invitro-
gen, Carlsbad, CA), and labeled for 30minwith 100 μCi/ml of Promix L-
[35S] cell labeling mix (GE Healthcare Life Sciences, Piscataway, NJ).
After pulse labeling, cells were lysed with RIPA buffer (20 mM TrisCl
[pH7.5], 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate,
0.1% SDS) containing 1× complete protease inhibitor cocktail (Roche
Applied Science, Indianapolis, IN) and electrophoresed on a Novex®
12% Tris-Glycine gel (Invitrogen, Carlsbad, CA) under the denaturing
condition and processed by autoradiography.
To label virions released from the infected cells, CEK cells were
labeledwith 40 μCi/ml of Pro-mix L-[35S] cell labelingmix inMet−/Cys−
DMEMat 4h postinfection for 12h. At 16 hp.i., the culturemediumwas
collected and clariﬁed by centrifugation at 14,000 rpm for 5 min. The
cleared culture supernatant was loaded over a 25% sucrose-NTE
(10 mM TrisCl, pH 7.5, 0.1 M NaCl, 10 mM EDTA) cushion and virions
werepelleted byultracentrifugation (30,000 rpm, 2h in SW55Ti rotor).
Virus pellets were dissolved in Tris-Glycine SDS sample buffer
(Invitrogen, Carlsbad, CA) and analyzed by electrophoresis and
autoradiography as described above.
RNA analysis
Viral RNA level in the infected cells was determined by Northern
blot and primer extension. MDCK cells were infected with each virus
and incubated at different temperatures. After the indicated time of
infection, total cellular RNAs were extracted using TRIzol® reagent
(Invitrogen, Carlsbad, CA). Approximately 1 μg of total RNA was
resolved on a 1.5% agarose-formaldehyde gel and blotted onto a nylon
membrane. Hybridization with strand-speciﬁc RNA probes was
performed according to manufacturer's instructions. Viral gene-
speciﬁc cDNA fragments were inserted into pCR2.1 (Invitrogen,
Carlsbad, CA) vector under the control of the T7 promoter to
synthesize sense-speciﬁc riboprobes that were transcribed in vitro
using [α-32P]-CTP (GE Healthcare Bio-Sciences, Piscataway, NJ) and
the MAXIscript T7 Kit (Ambion, Austin, TX).
Primer extension analysis was used to quantitatively detect vRNA,
mRNA and cRNA. Approximately 4–5 μg of total RNA was mixed with
an excess amount (1 μl each of 50 μM primer) of viral gene-speciﬁc
primers end labeled with [γ-32P] ATP and T4 polynucleotide kinase
(GE Healthcare Life Sciences, Piscataway, NJ). Primer sequences are
available upon request. One set of primers were designed to detect the
NP, M and PAvRNAs and the second set of primers were synthesized to
detect bothmRNAs and cRNAs of the NP, M and PA gene segments. The
mRNA is differentiated from cRNA because of its capped primer
361Z. Chen et al. / Virology 380 (2008) 354–362sequences that are usually 10–15 nt longer than the cRNA. The RNA
and primer mixture was denatured at 95 °C for 3 min and annealed at
room temperature for 10 min. Following the addition of 200 U of
Superscript II Reverse Transcriptase (Invitrogen, Carlsbad, CA), primer
extensionwas performed at 42 °C for 1 h. The labeled cDNA transcript
products were separated on a 6% polyacrylamide gel containing 7 M
Urea and detected by autoradiography.
Analysis of polymerase protein function by a minigenome assay
Plasmids pAB121-PB1, pAB122-PB2, pAB123-PA and pAB125-NP
encoding PB1, PB2, PA and NP of MDV-B have been described
previously (Hoffmann et al., 2005). The pHW-EGFP reporter plasmid
contains human pol I promoter that controls transcription of the EGFP
cDNA (negative sense) ﬂanked by the noncoding sequences derived
from the inﬂuenza B virus NS gene segment (Hoffmann et al., 2005).
The expression of the EGFP reporter gene is dependent on viral
polymerase proteins, PA, PB1, PB2 and NP. To examine the polymerase
function at different temperatures, pHW-EGFP reporter plasmid was
cotransfected into 293T cells together with the plasmids encoding the
PB1, PB2, PA and NP using TransIT-LT1 transfection reagent (Mirus,
Madison, WI) following the manufacturer's instructions. After incuba-
tion at 33 and 37 °C for 48 h, the expression of EGFP was visualized
under an immunoﬂuorescence microscope and the images were
captured by a digital camera. The transfected cell lysates were
analyzed by Western blot with an anti-GFP antibody (Clontech,
Mountain View, CA). The level of GFP expression was also quantitated
by ﬂow cytometry (Becton Dickinson FACSCalibur, BD BioSciences, San
Jose, CA).
Western blot
Viral proteins in infected cells and virions were examined by
Western blot analysis. CEK cells at 100% conﬂuency were inoculated
with virus at the indicated MOI and incubated at 33 °C for 15 h. The
culture supernatant was collected and cellular debris was removed by
centrifugation in microcentrifuge at 14,000 rpm for 5 min. The
infected cells were lysed in 1× RIPA buffer. The cell lysate and released
virions in the clariﬁed culture supernatants were suspended in Tris-
Glycine SDS sample buffer and electrophoresed on a Novex® 12% Tris-
Glycine gel. The proteins were transferred to a nitrocellulose
membrane and blotted with a rabbit anti-inﬂuenza antiserum which
can detect HA and NP (Takara Bio USA, Madison, WI). To detect M1
proteins, a guinea pig antiserumwas produced against the M1 protein
puriﬁed from MDV-B virus.
Membrane ﬂoatation analysis
Viral protein membrane association was studied by membrane
ﬂoatation analysis. Radiolabeling, subcellular fractionation and ﬂoata-
tion of virus-infected cells were performed as described by Ali et al
(Ali et al., 2000) with some modiﬁcations. CEK cells in 10-cm dishes
were infected with virus at an MOI of 4 at 33 or 37 °C for 12 h and
labeled with 100 μCi/ml of Promix L-[35S] cell labeling mix in Met−/Cys
− DMEM for 30 min. The labeling medium was then replaced with
DMEM and chased for 90 min. To prepare subcellular fractions, [35S]
pulsed-chased cells were washed with ice-cold PBS, scraped from
dishes, and pelleted by centrifugation at 2000 g for 5 min. The cell
pellet was resuspended in 1ml of hypotonic lysis buffer (10mMTrisCl,
pH 7.5, 10 mM KCl, 5 mM MgCl2) and disrupted by repeated passages
(20–25 times) through a 28 gauge hypodermic needle. After
centrifugation at 1000 g for 5 min, the postnuclear supernatant was
subjected to the ﬂoatation analysis. About 0.5 ml of postnuclear
supernatant was made to contain 70% (w/v) sucrose in 2 ml of low-
salt-buffer (LSB, 50 mM TrisCl, pH7.5, 25 mM KCl, 5 mM MgCl2),
overlaid with 2 ml of 55% sucrose and 0.6 ml of 5% sucrose in LSB. Thegradients were centrifuged at 38,000 rpm for 18 h in a SW55Ti rotor.
The top 2 ml of fraction was collected as the membrane fraction
(insoluble) and the bottom 3 ml of fraction as the non-membrane
associated (soluble) proteins. Each fraction was diluted with an equal
volume of 2× RIPA buffer and incubated at 4 °C for 2 h in a rocker. Viral
proteins in each faction were immunoprecipitated with an MDV-B
polyclonal antibody, electrophoresed on a Novex® 12% Tris-Glycine gel
under the denaturing condition and processed by autoradiography.
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